FEATURED
COVID 19 Articles
Fox and Endemol Shine Team to Adapt ‘Fear Factor’ as a Scripted Microdrama Series for My Drama App
Fox and Endemol Shine are adapting ‘Fear Factor’ as a scripted horror microdrama series consisting of 30 three-minute episodes for the My Drama app.
Broadway Box Office: Billy Crystal’s ‘860’ Sees Strong Opening, As ‘Downstate’ and More Start Previews
Billy Crystal’s solo show “860” opened to largely positive reviews and strong attendance, while several other Broadway productions began previews as the fall season progresses.
The ‘trillion pound’ oil fund the government believes Britain could have built
Britain has created an Energy Wealth Fund with £2bn in funding, marking its first sovereign wealth fund after decades. Treasury analysis suggests historical North Sea oil revenues could have grown to £1 trillion had they been invested systematically decades ago.
Is an ‘AI war’ complicating your job search?
A growing number of job seekers report facing hundreds of rejections, often without human review, as employers increasingly rely on AI recruitment tools to screen applications amid concerns about bias and fairness.
Trending COVID 19 News
Household energy bills to hit three-year high as Ofgem announces 4% rise from October
UK energy regulator Ofgem announced a 4% increase to the price cap effective 1 October, raising typical household bills by £60 annually amid higher wholesale gas costs tied to geopolitical tensions.
Meta to pay up to $18bn to settle claims its platforms harm children
Meta has agreed to an $18 billion settlement with US states to resolve child safety claims and will implement new protections including default time limits and night-time notification blocks.
Lost in limbo: Where the Paramount merger delay leaves WBD, and what may come next
Warner Bros. Discovery’s proposed merger with Paramount faces regulatory delays and uncertainty, leaving the company unable to execute major strategic initiatives while awaiting deal closure.
The White House’s preferred economic tools are hitting snags
The Trump administration’s export controls and tariffs, intended to protect economic security, are facing delays, legal setbacks, and widespread fraud schemes that undermine their effectiveness.
Qantas may hike fares and expand Jetstar add-on fees as profits dip to four-year low
Qantas reported its lowest pre-tax profits in four years due to fuel costs, signaling potential fare increases and expanded add-on fees for budget carrier Jetstar.
City firms race to prepare for FCA crackdown on bullying and harassment
The FCA will expand its crackdown on bullying and harassment to approximately 40,000 investment firms, hedge funds, and brokers starting next month, requiring companies to report serious misconduct cases.
Canada announces ‘dollar-for-dollar’ retaliatory tariffs on US as high as 50%
Canada announced retaliatory tariffs as high as 50% on nearly C$28 billion worth of US goods, effective September 8, following the collapse of trade talks and Trump administration levies on Canadian imports.
Thursday briefing: Will the government reform the system to bring down our energy bills?
Britain’s energy price cap is rising 4% from October to £1,723 annually, prompting calls for government reform despite recent VAT cuts and promises of relief from cost-of-living pressures.
Pakistan PIMS fire: Witnesses say door was locked as Islamabad hospital blaze killed 14 babies
A fire at a Pakistani hospital’s maternity ward killed 14 infants on Wednesday morning. Witnesses dispute accounts of rescue response times and ward access protocols.
South African police arrest two Thai men for allegedly smuggling parrot eggs
South African authorities arrested two Thai nationals in separate incidents for allegedly attempting to smuggle endangered parrot eggs out of the country, seizing hundreds of eggs in homemade incubators.
Key moments from Lindsay Clancy’s five-week trial over children’s killings
Lindsay Clancy’s five-week trial concludes with closing arguments Thursday. The Massachusetts mother admits killing her three children but claims severe mental illness should exempt her from legal responsibility.
FDA approves breakthrough drug daraxonrasib to treat pancreatic cancer
The FDA approved daraxonrasib, a pancreatic cancer treatment that nearly doubled survival time to 13.2 months in clinical trials, compared to 6.6 months with chemotherapy.